1. Home
  2. SHIM vs CNTX Comparison

SHIM vs CNTX Comparison

Compare SHIM & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shimmick Corporation

SHIM

Shimmick Corporation

HOLD

Current Price

$3.14

Market Cap

97.5M

Sector

N/A

ML Signal

HOLD

Logo Context Therapeutics Inc.

CNTX

Context Therapeutics Inc.

HOLD

Current Price

$1.19

Market Cap

116.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHIM
CNTX
Founded
1990
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.5M
116.7M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
SHIM
CNTX
Price
$3.14
$1.19
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$5.67
AVG Volume (30 Days)
37.3K
680.8K
Earning Date
11-13-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$495,984,000.00
N/A
Revenue This Year
$6.91
N/A
Revenue Next Year
$13.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.30
$0.49
52 Week High
$3.50
$1.55

Technical Indicators

Market Signals
Indicator
SHIM
CNTX
Relative Strength Index (RSI) 68.37 57.08
Support Level $2.60 $1.08
Resistance Level $2.98 $1.34
Average True Range (ATR) 0.20 0.10
MACD 0.04 0.01
Stochastic Oscillator 78.41 64.18

Price Performance

Historical Comparison
SHIM
CNTX

About SHIM Shimmick Corporation

Shimmick Corp is a provider of water and other critical infrastructure solutions nationwide. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure, including desalination plants. In water resources projects company builds, expands, and improves water storage and conveyance, dams, levees, flood control systems, pump stations, and coastal protection. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains its nation's critical infrastructure, including mass transit, bridges, and military infrastructure.

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Share on Social Networks: